[ad_1]
Add professional pharmacy management services to expand the advanced service portfolio to support the acquisition and management of complex drugs
Expected to increase Omnicell’s non-GAAP EBITDA in the first quarter of 2023
Omnicell, Inc. (NASDAQ stock code:OMCL), a leading provider of medication management solutions and compliance tools for health systems and pharmacies, has completed the previously announced acquisition of ReCept Holdings, Inc. ReCept adds specialized pharmacy management services (FQHCs) to the health system, supplier groups, and federally qualified health centers, and expands Omnicell’s advanced service portfolio to address the growing and complex specialty pharmacy market.
ReCept provides implementation and management services for health systems and other provider organizations to optimize their professional pharmacy plans and the drug-related aspects of patient care. The overall solution supports on-site management, including payer contracts, staffing, licensing, quality assurance, 340B management, and preferred pricing agreements designed to increase profits and profitability, while placing patients in the care center.
“ReCept’s professional pharmacy management service capabilities naturally complement Omnicell’s smart infrastructure, providing us with deeper expertise to meet the growing market demand for managing complex professional drugs, as a broader and more comprehensive drug management strategy. Part,” said Randall Lips, chairman, president and CEO, and founder of Omnicell.
According to the terms of the acquisition agreement, the acquisition price was US$100 million, which was adjusted conventionally in accordance with the provisions of the agreement and the merger plan. …
The full story on Benzinga.com
[ad_2]
Source link
